Mortality after acute kidney injury and acute interstitial nephritis in patients prescribed immune checkpoint inhibitor therapy

Mortality after acute kidney injury and acute interstitial nephritis in patients prescribed immune checkpoint inhibitor therapy

Background In patients receiving immune checkpoint inhibitor (ICI) therapy, acute kidney injury (AKI) is common, and can occur either from kidney injury unrelated to ICI use or from immune activation resulting in acute interstitial nephritis (AIN). In this study, we test the hypothesis that occurren...

Full description

Bibliographic Details
Main Authors: Yu Yamamoto, Nazli Dizman, F Perry Wilson, Dennis G Moledina, Chirag R Parikh, Michael Simonov, Navid Hafez, Megan L Baker, Mark A Perazella, Anushree C Shirali, Jason Weinstein, Jeffrey M Testani, Lloyd G Cantley
Format: Article
Language:English
Published: BMJ Publishing Group 2022-03-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/10/3/e004421.full

Internet

https://jitc.bmj.com/content/10/3/e004421.full

Similar Items